A detailed history of Lincoln Capital Corp transactions in Pfizer Inc stock. As of the latest transaction made, Lincoln Capital Corp holds 11,100 shares of PFE stock, worth $292,596. This represents 0.13% of its overall portfolio holdings.

Number of Shares
11,100
Previous 11,100 -0.0%
Holding current value
$292,596
Previous $310,000 3.55%
% of portfolio
0.13%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$25.26 - $29.6 $42,840 - $50,201
1,696 Added 18.03%
11,100 $310,000
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $243,469 - $279,580
9,404 New
9,404 $260,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lincoln Capital Corp Portfolio

Follow Lincoln Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital Corp with notifications on news.